Ulf Schröder

1.3k total citations
40 papers, 1.0k citations indexed

About

Ulf Schröder is a scholar working on Immunology, Epidemiology and Atomic and Molecular Physics, and Optics. According to data from OpenAlex, Ulf Schröder has authored 40 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 11 papers in Epidemiology and 10 papers in Atomic and Molecular Physics, and Optics. Recurrent topics in Ulf Schröder's work include Catalytic Processes in Materials Science (8 papers), Advanced Chemical Physics Studies (7 papers) and Immune Response and Inflammation (6 papers). Ulf Schröder is often cited by papers focused on Catalytic Processes in Materials Science (8 papers), Advanced Chemical Physics Studies (7 papers) and Immune Response and Inflammation (6 papers). Ulf Schröder collaborates with scholars based in Sweden, Germany and United States. Ulf Schröder's co-authors include Klaus Mosbach, Beston Hamasur, A Pawłowski, Gunilla Källenius, S.B. Svenson, Jorma Hinkula, Britta Wahrén, Claudia Devito, K. Wandelt and R. Linke and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Ulf Schröder

39 papers receiving 968 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ulf Schröder Sweden 18 364 344 312 170 147 40 1.0k
Adam C. Finnefrock United States 23 246 0.7× 329 1.0× 439 1.4× 395 2.3× 181 1.2× 47 1.7k
Arnab Basu India 26 139 0.4× 481 1.4× 358 1.1× 436 2.6× 126 0.9× 78 2.0k
Francisco Javier Chichón Spain 18 133 0.4× 142 0.4× 233 0.7× 409 2.4× 151 1.0× 30 1.1k
Mary S. Collins United States 20 228 0.6× 169 0.5× 614 2.0× 170 1.0× 41 0.3× 31 1.6k
Narendra M. Dixit India 24 679 1.9× 300 0.9× 442 1.4× 414 2.4× 79 0.5× 80 2.1k
Norman R. Watts United States 25 199 0.5× 97 0.3× 496 1.6× 774 4.6× 72 0.5× 56 1.7k
Isabel Haro Spain 23 203 0.6× 236 0.7× 402 1.3× 998 5.9× 108 0.7× 189 2.1k
Brenda D. Spangler United States 11 282 0.8× 479 1.4× 113 0.4× 552 3.2× 138 0.9× 16 1.6k
Wenping He United States 21 196 0.5× 75 0.2× 354 1.1× 347 2.0× 450 3.1× 28 1.5k
Frank Y.S. Chuang United States 14 170 0.5× 301 0.9× 281 0.9× 496 2.9× 176 1.2× 27 1.4k

Countries citing papers authored by Ulf Schröder

Since Specialization
Citations

This map shows the geographic impact of Ulf Schröder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulf Schröder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulf Schröder more than expected).

Fields of papers citing papers by Ulf Schröder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulf Schröder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulf Schröder. The network helps show where Ulf Schröder may publish in the future.

Co-authorship network of co-authors of Ulf Schröder

This figure shows the co-authorship network connecting the top 25 collaborators of Ulf Schröder. A scholar is included among the top collaborators of Ulf Schröder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulf Schröder. Ulf Schröder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bråve, Andreas, et al.. (2013). Endocine™, N3OA and N3OASq; Three Mucosal Adjuvants That Enhance the Immune Response to Nasal Influenza Vaccination. PLoS ONE. 8(8). e70527–e70527. 14 indexed citations
2.
Brytting, Mia, et al.. (2010). The Eurocine® L3 adjuvants with subunit influenza antigens induce protective immunity in mice after intranasal vaccination. Vaccine. 28(39). 6491–6497. 13 indexed citations
3.
Hinkula, Jorma, Marie Hagbom, Britta Wahrén, & Ulf Schröder. (2008). Safety and immunogenicity, after nasal application of HIV-1 DNA gagp37 plasmid vaccine in young mice. Vaccine. 26(40). 5101–5106. 8 indexed citations
4.
Bråve, Andreas, David Hallengärd, Ulf Schröder, et al.. (2008). Intranasal immunization of young mice with a multigene HIV-1 vaccine in combination with the N3 adjuvant induces mucosal and systemic immune responses. Vaccine. 26(40). 5075–5078. 17 indexed citations
5.
Buonaguro, Luigi, Claudia Devito, Maria Lina Tornesello, et al.. (2007). DNA–VLP prime–boost intra-nasal immunization induces cellular and humoral anti-HIV-1 systemic and mucosal immunity with cross-clade neutralizing activity. Vaccine. 25(32). 5968–5977. 55 indexed citations
6.
Hamasur, Beston, Dolores Gavier‐Widén, Mark A. Chambers, et al.. (2005). Nasal boost with adjuvanted heat-killed BCG or arabinomannan–protein conjugate improves primary BCG-induced protection in C57BL/6 mice. Tuberculosis. 85(1-2). 107–114. 32 indexed citations
7.
Hinkula, Jorma, Claudia Devito, Bartek Zuber, et al.. (2005). A novel DNA adjuvant, N3, enhances mucosal and systemic immune responses induced by HIV-1 DNA and peptide immunizations. Vaccine. 24(21). 4494–4497. 25 indexed citations
8.
Hamasur, Beston, et al.. (2004). A mycobacterial lipoarabinomannan specific monoclonal antibody and its F(ab′)2 fragment prolong survival of mice infected with Mycobacterium tuberculosis. Clinical & Experimental Immunology. 138(1). 30–38. 141 indexed citations
9.
Devito, Claudia, Bartek Zuber, Ulf Schröder, et al.. (2004). Intranasal HIV-1-gp160-DNA/gp41 Peptide Prime-Boost Immunization Regimen in Mice Results in Long-Term HIV-1 Neutralizing Humoral Mucosal and Systemic Immunity. The Journal of Immunology. 173(11). 7078–7089. 54 indexed citations
10.
Johansen, Kari, Ulf Schröder, & Lennart Svensson. (2003). Immunogenicity and protective efficacy of a formalin-inactivated rotavirus vaccine combined with lipid adjuvants. Vaccine. 21(5-6). 368–375. 26 indexed citations
11.
Hamasur, Beston, Melles Haile, A Pawłowski, et al.. (2003). Mycobacterium tuberculosis arabinomannan–protein conjugates protect against tuberculosis. Vaccine. 21(25-26). 4081–4093. 85 indexed citations
12.
13.
Wéber, A., Ulf Schröder, Adrien May, C. von Ilberg, & E. Frömter. (1997). Chloridleitfähigkeit nasaler Fibroblasten von Polyposis-Patienten mit zystischer Fibrose und Patienten ohne zystische Fibrose. HNO. 45(9). 695–701. 1 indexed citations
14.
Schröder, Ulf, B. J. McIntyre, Miquel Salmerón, & Gábor A. Somorjai. (1995). Spatially controlled oxidation by the tip of a scanning tunneling microscope operating inside a reactor. Surface Science. 331-333. 337–342. 11 indexed citations
15.
Schröder, Ulf. (1994). Kinetic Oscillations During Acetylene Hydrogenation over Pt/Al2O3 and Pd/Al2O3 in the Presence of CO. Journal of Catalysis. 146(2). 586–590. 6 indexed citations
16.
17.
Fahlvik, Anne K., et al.. (1990). Magnetic Starch Microspheres, Efficacy and Elimination A New Organ-Specific Contrast Agent for Magnetic Resonance Imaging. Investigative Radiology. 25(2). 113–120. 26 indexed citations
18.
Fahlvik, Anne K., E. Holtz, Ulf Schröder, & Jo Klaveness. (1990). Magnetic Starch Microspheres, Biodistribution and Biotransformation. Investigative Radiology. 25(7). 793–797. 23 indexed citations
19.
Schröder, Ulf. (1985). [9] Crystallized carbohydrate spheres for slow release and targeting. Methods in enzymology on CD-ROM/Methods in enzymology. 112. 116–128. 2 indexed citations
20.
Schröder, Ulf & Klaus Mosbach. (1982). Magnetic microspheres for targeting of drugs. Applied Biochemistry and Biotechnology. 7(1-2). 63–65. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adam C. Finnefrock Breakdown of academic impact, for papers by Arnab Basu Breakdown of academic impact, for papers by Francisco Javier Chichón Breakdown of academic impact, for papers by Mary S. Collins Breakdown of academic impact, for papers by Narendra M. Dixit Breakdown of academic impact, for papers by Norman R. Watts Breakdown of academic impact, for papers by Isabel Haro Breakdown of academic impact, for papers by Brenda D. Spangler Breakdown of academic impact, for papers by Wenping He Breakdown of academic impact, for papers by Frank Y.S. Chuang
Rankless by CCL
2026